Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.65 +0.13 (+0.44%)
At close: Sep 30, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Accounts Payables (2013 - 2026)

Updated

Lakefront Biotherapeutics' Accounts Payables came in at $112.12 million for the quarter ended Mar 31, 2026, down 36.9% from $177.71 million a year earlier and down 8.0% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Accounts Payables (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Lakefront Biotherapeutics' Accounts Payables was $118.23 million, up 10.5% from the prior year.

  • Accounts Payables carries a five-year compound annual growth rate of -77.4% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Accounts Payables was $107.02 million in the year ended Dec 31, 2024 (-26.4%), $145.47 million in the year ended Dec 31, 2023 (-99.9%), $156.7 billion in the year ended Dec 31, 2022 (-3.8%) and $162.86 billion in the year ended Dec 31, 2021 (-18.7%).
  • The figure for the quarter ended Mar 31, 2026 represents the lowest quarterly Accounts Payables since the quarter ended Dec 31, 2024.
  • Year-over-year, Accounts Payables increased in two of the last six quarters, with an average decline of 7.9%.
  • The fastest year-over-year change in Accounts Payables over five years came in the quarter ended Dec 31, 2025 (growth of 15.3%), and the weakest in the quarter ended Dec 31, 2023 (a decline of 99.9%).
  • Business Quant data shows LKFT's Accounts Payables at $121.81 million (quarter ended Dec 31, 2025), $117.65 million (quarter ended Sep 30, 2025) and $150.75 million (quarter ended Jun 30, 2025) in the three quarters before the quarter ended Mar 31, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Lakefront Biotherapeutics 1.95 Bn 1.95 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 112.12 Mn
Dec 31, 2025 121.81 Mn
Sep 30, 2025 117.65 Mn
Jun 30, 2025 150.75 Mn
Mar 31, 2025 177.71 Mn
Dec 31, 2024 105.66 Mn
Sep 30, 2024 127.24 Mn
Mar 31, 2024 158.12 Mn
Dec 31, 2023 145.47 Mn
Sep 30, 2023 131.86 Mn
Mar 31, 2023 167.39 Mn
Dec 31, 2022 151.69 Bn
Mar 31, 2022 151.14 Mn
Dec 31, 2021 157.44 Bn
Jun 30, 2021 182.71 Mn
Dec 31, 2020 209.31 Bn
Jun 30, 2020 197.64 Mn
Mar 31, 2020 187.09 Mn
Dec 31, 2019 158.77 Mn
Sep 30, 2019 173.87 Mn
API Access

Lakefront Biotherapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=LKFT&period=max&api_key=YOUR_API_KEY